NOT-AI-26-006: Notice of Early Expiration of PAR-25-099, "Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)"

Notice of Early Expiration of PAR-25-099, "Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)"

Notice Number:

NOT-AI-26-006

Key Dates

Release Date:

February 19, 2026

Related Announcements

December 30, 2024 - Planning for Product Development Strategy (R34 Clinical Trial Not Allowed). See NOFO PAR-25-099.

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform the extramural community that PAR-25-099, “Planning for Product Development Strategy (R34 Clinical Trial Not Allowed),” will be expired effective immediately. No further applications will be accepted for this notice of funding opportunity (NOFO).

Inquiries

Please direct all inquiries to:

National Institute of Allergy and Infectious Diseases (NIAID)
[email protected]